CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children

JAMA

Volumn 279, Issue 4, 1998, Pages 277-280

  Misrahi, Micheline ^a   Teglas, Jean Paul ^b   N'Go, Nicole ^c   Burgard, Marianne ^c   Mayaux, Marie Jeanne ^b   Rouzioux, Christine ^c   Delfraissy, Jean François ^b   Blanche, Stéphane ^c  

^a Unite 292

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; DNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ALLELE; ARTICLE; CAPILLARY ELECTROPHORESIS; CHILD; CLINICAL TRIAL; DISEASE COURSE; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS CULTURE;

EID: 0032573896     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.4.277     Document Type: Article

References (34)

1. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 co-receptors accounts for resistance for some multiply exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.
2. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722-725.
3. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996;273:1856-1862.
4. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996;11:1240-1243.
5. Michael NL, Chang C, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med. 1997;3:338-340.
6. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background and quantified risk. Mol Med. 1997;3:23-26.
7. Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med. 1997; 3:252-253.
8. O'Brien TR, Winkler C, Dean M, et al. HIV-1 infection in a man homozygous for CCR5 Δ32. Lancet. 1997;349:1219.
9. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C and the Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5A32: Seroco Study Group. Lancet. 1997;349:1219-1220.
10. Balotta C, Bagnarelli P, Violin M, et al. Homozygous Δ32 deletion of the CCR-5 chemokine receptor gene in an HIV-1 infected patient. AIDS. 1997; 11:F67-F71.
11. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR5 Δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS. 1997,11:5908-5913.
12. Husman de Roda AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med. 1997;127:882-890.
13. Smith MW, Dean M, Carrington M, Huttley GA, O'Brien SJ. CCR5-Δ32 gene deletion in HIV-1 infected patients. Lancet. 1997;350:741.
14. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. J Acquir Immun Defic Syndr Hum Retrovirol. 1995;8:188-194.
15. Fang G, Burger H, Grimson R, et al. Maternal plasma HIV-1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci U S A. 1995;92:12100-12104.
16. Dickover RE, Garraty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA. 1996;275:599-605.
17. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal viral load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1:the French Perinatal Cohort Studies. J Infect Dis. 1997;175:172-175.
18. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med. 1996;334:1617-1623.
19. Mandelbrot L, Mayaux MJ, Bongain F, et al. Obstetric factors and mother-to-child transmission of human immunodefiency virus type 1:the French perinatal cohorts: SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol. 1996;175:661-667.
20. Wolinsky SM, Wike CM, Korber BTM, et al. Selective transmission of human immunodeficiency virus type 1 variants from mothers to infants. Science. 1992;255:1134-1137.
21. Scarlatti G, Leitner T, Halapi E, et al. Comparison of variable sequence region 3 of HIV-1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A. 1993;90:1721-1725.
22. Revised classification for HIV-1 infection in children. MMWR Morb Mortal Wkly Rep. 1994;43(RR-12):1-10.
23. Strachan T, Read AP. Human Molecular Genetics. Oxford, England: Bios Scientific Publishers Ltd; 1996.
24. Blanche S, Mayaux MJ, Rouzioux C, et al. Relationship of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med. 1994;330:308-312.
25. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA. 1996;275:606-610.
26. Martinson JJ, Chapman NH, Rees DC, Yan-Tat Liu, Clegg JB. Global distribution of the CCR5 gene 32-base pair deletion. Nat Genet. 1997; 16:100-103.
27. Kourtis AP, Ibegbu C, Nahmias AJ, et al. Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med. 1996;335:1431-1436.
28. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex HLA class II DR allele DR B1 1501 and those encoding HLA DR 13 are preferentially associated with a diminution in maternally transmitted HIV-1 in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A. 1995;92:12374-12378.
29. Just JJ, Abrams E, Louie LG, et al. Influence of host genotype on progression to acquired immunodeficiency syndrome among children with human immunodeficiency virus type 1. J Pediatr. 1995;127: 544-549.
30. Hill AV. HIV and HLA: confusion or complexity. Nat Med. 1996;2:395-396.
31. Moore JP. Co-receptors: implications for HIV pathogenesis and therapy. Science. 1997;276:51-52.
32. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 1997;277:959-965.
33. Michael NL, Louie LG, Rohrbaugh AL, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med. 1997;3:1160-1162.
34. Simmons G, Clapham PR, Picard L, et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 1997;276:276-279.